BRWA
DMK

B. Riley Wealth Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

B. Riley Wealth Advisors’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-286
Closed -$2.32K – 1673
2023
Q1 		$2.32K Hold
286
– – ﹤0.01% 1510
2022
Q4 		$3.39K Sell
286
-21
-7% -$240 ﹤0.01% 1485
2022
Q3 		$5K Sell
307
-53
-15% -$1.37K ﹤0.01% 1442
2022
Q2 		$13K Hold
360
– – ﹤0.01% 1215
2022
Q1 		$15K Hold
360
– – ﹤0.01% 1368
2021
Q4 		$16K Hold
360
– – ﹤0.01% 1400
2021
Q3 		$25K Hold
360
– – ﹤0.01% 1389
2021
Q2 		$28K Buy
360
+10
+3% +$609 ﹤0.01% 1359
2021
Q1 		$24K Sell
350
-186
-35% -$14.5K ﹤0.01% 1338
2020
Q4 		$19K Sell
536
-21
-4% -$934 ﹤0.01% 1022
2020
Q3 		$31K Buy
557
+21
+4% +$1.25K ﹤0.01% 931
2020
Q2 		$21K Hold
536
– – ﹤0.01% 856
2020
Q1 		$14K Hold
536
– – ﹤0.01% 782
2019
Q4 		$27K Hold
536
– – ﹤0.01% 826
2019
Q3 		$27K Buy
536
+123
+30% +$8.84K ﹤0.01% 799
2019
Q2 		$38K Sell
413
-14
-3% -$1.7K ﹤0.01% 780
2019
Q1 		$64K Buy
427
+95
+29% +$18.4K 0.01% 716
2018
Q4 		$53K Hold
332
– – 0.01% 644
2018
Q3 		$82K Buy
332
+27
+9% +$6.39K 0.01% 694
2018
Q2 		$69K Sell
305
-23
-7% -$6.16K 0.01% 654
2018
Q1 		$81K Buy
328
+7
+2% +$1.84K 0.01% 635
2017
Q4 		$99K Buy
+321
New +$106K 0.01% 614
2017
Q1 		– Sell
-236
Closed -$52K – 567
2016
Q4 		$52K Hold
236
– – 0.01% 517
2016
Q3 		$57K Buy
236
+7
+3% +$1.46K 0.01% 593
2016
Q2 		$45K Buy
+229
New +$106K 0.01% 593

Other funds holding DMK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

B. Riley Wealth Advisors's DMK Position: Q2 2023 in Review

B. Riley Wealth Advisors sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 286 shares — an estimated $2.32K sold.

B. Riley Wealth Advisors first reported a position in DMK in Q2 2016 and held it in 25 quarters. The position peaked at $99K in Q4 2017. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

  • B. Riley Wealth Advisors reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 286 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $2.32K.
  • B. Riley Wealth Advisors first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2016 and held it in 25 quarters.
  • B. Riley Wealth Advisors's DMK Pharmaceuticals Corporation Common Stock position peaked at $99K in Q4 2017.
  • 22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2023, filed 27 Jul 2023.